Default Prediction for 2016-12-31 Default prediction by Z-Score (what's this?) . Z Score : 5.9692 ... Default Prediction for 2016-12-31 Default prediction by Z-Score (what's this?) . Z Score : 5.9692 ... Click on the image for the high resolution version. * Stock quotes on TextBiz are always adjusted... Click on the image for the high resolution version. * Stock quotes on TextBiz are always adjusted... Fundamental Analysis for 2017 Fundamental Analysis metrics & ratios (what's this?) . Date of... Fundamental Analysis for 2017 Fundamental Analysis metrics & ratios (what's this?) . Date of... Fundamental Analysis for 2017 Fundamental Analysis metrics & ratios (what's this?) . Date of... Fundamental Analysis for 2017 Fundamental Analysis metrics & ratios (what's this?) . Date of... 11.2265 11.2265 Alex Lash October 7th 2016 @alexlash @xconomy Like Us Xconomy National — [ Updated 11:50 a.m... Alex Lash October 7th, 2016 @alexlash @xconomy Like Us Xconomy National — [ Updated, 11:50 a.m... 11.2265 11.2265 View the other companies in the same industry : Biotechnology & Medical Research Alternative... View the other companies in the same industry : Biotechnology & Medical Research Alternative... Industry Industry Data Provider: Data is provided by Zacks Investment Research Data Provider: Data is provided by Zacks Investment Research BLOOMBERG NEWS/FILE 2007 Alnylam’s John Maraganore described the Genzyme deal as “transformational... BLOOMBERG NEWS/FILE 2007 Alnylam’s John Maraganore described the Genzyme deal as “transformational... Stuart Milstein Alnylam Pharmaceuticals Cambridge MA Stuart Milstein Alnylam Pharmaceuticals Cambridge, MA Data Provider: Data is provided by Zacks Investment Research Data Provider: Data is provided by Zacks Investment Research GETTY Britain has received another Brexit boost The US firm is set to hire a new team of more than... GETTY Britain has received another Brexit boost The US firm is set to hire a new team of more than... 10/6/2016 2:09 AM ET Shares of Alnylam Pharmaceuticals Inc. ( ALNY ) plunged more than 41% in... 10/6/2016 2:09 AM ET Shares of Alnylam Pharmaceuticals Inc. ( ALNY ) plunged more than 41% in... On August 10 the US Food and Drug Administration approved the first RNA interference (RNAi)... On August 10, the US Food and Drug Administration approved the first RNA interference (RNAi)... Alnylam社のFAP研究者と スシロールが美味しそう Alnylam社のFAP研究者と スシロールが美味しそう Web Page: www.Alnylam.com Back to Asymmetric Synthesis: A Symposium in Honor of Ernest Eliel... Web Page: www.Alnylam.com Back to Asymmetric Synthesis: A Symposium in Honor of Ernest Eliel... Alnylam社のFAP研究者と スシロールが美味しそう Alnylam社のFAP研究者と スシロールが美味しそう Orbimed is the world’s largest healthcare-dedicated investment firm. The firm has with... Orbimed is the world’s largest healthcare-dedicated investment firm. The firm has with... Fundamental Analysis for 2017 Fundamental Analysis metrics & ratios (what's this?) . Date of... Fundamental Analysis for 2017 Fundamental Analysis metrics & ratios (what's this?) . Date of... 11.2265 11.2265 Industry Industry アルナイラム社の研究者達からは熱心な質問が アルナイラム社の研究者達からは熱心な質問が Fundamental Analysis for 2017 Fundamental Analysis metrics & ratios (what's this?) . Date of... Fundamental Analysis for 2017 Fundamental Analysis metrics & ratios (what's this?) . Date of... アルナイラム社の研究者達からは熱心な質問が アルナイラム社の研究者達からは熱心な質問が 11.2265 11.2265 View the other companies in the same industry : Biotechnology & Medical Research Alternative... View the other companies in the same industry : Biotechnology & Medical Research Alternative...
Siguiente »
Búsqueda avanzada